Determination of Salivary Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Hypoxia-inducible Factor-1 Alpha (HIF-1α), E-cadherin, Galectin 3, IL-4, IL-10 and TNF-α Levels in Individuals With Different Degrees of Periodontal Disease
N/A
The aim of this clinical study is; Comparatively comparing salivary Soluble...
Prognostic Value of Soluble Urokinase Plasminogen Activation Receptor (SUPAR) to Rule Out Complications in Patients Admitted in Emergency Department for Acute Abdominal Pain.
N/A
Soluble Urokinase Plasminogen Activation Receptor (SUPAR) is a validated bi...
The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Post-acute Phase of the Infection by Covid-19
N/A
More than 660 million cases of COVID-19 have been reported worldwide, with ...
Status
Recruiting
Location
10th Department of Pulmonary Medicine, Sotiria Athens Hospital of Chest Diseases